CN1249081C - 糖肽衍生物或含有它们的药物组合物 - Google Patents

糖肽衍生物或含有它们的药物组合物 Download PDF

Info

Publication number
CN1249081C
CN1249081C CNB99809434XA CN99809434A CN1249081C CN 1249081 C CN1249081 C CN 1249081C CN B99809434X A CNB99809434X A CN B99809434XA CN 99809434 A CN99809434 A CN 99809434A CN 1249081 C CN1249081 C CN 1249081C
Authority
CN
China
Prior art keywords
hydrogen
substituted
cooh
alkyl
glycosamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB99809434XA
Other languages
English (en)
Chinese (zh)
Other versions
CN1315961A (zh
Inventor
J·K·朱迪斯
P·R·法瑟里
B·M·T·兰姆
M·里德伯特
M·S·林塞尔
穆永琪
S·G·特莱普
杨光
朱严
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cumberland Pharmaceuticals Inc
Original Assignee
Shiwan Pharmaceutical
Advanced Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiwan Pharmaceutical, Advanced Medicine Inc filed Critical Shiwan Pharmaceutical
Publication of CN1315961A publication Critical patent/CN1315961A/zh
Application granted granted Critical
Publication of CN1249081C publication Critical patent/CN1249081C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CNB99809434XA 1998-12-23 1999-12-22 糖肽衍生物或含有它们的药物组合物 Expired - Lifetime CN1249081C (zh)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US11372898P 1998-12-23 1998-12-23
US60/113,728 1998-12-23
US12931399P 1999-04-14 1999-04-14
US60/129,313 1999-04-14
US16402499P 1999-11-04 1999-11-04
US60/164,024 1999-11-04
US16997899P 1999-12-10 1999-12-10
US60/169,978 1999-12-10

Publications (2)

Publication Number Publication Date
CN1315961A CN1315961A (zh) 2001-10-03
CN1249081C true CN1249081C (zh) 2006-04-05

Family

ID=27493926

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB99809434XA Expired - Lifetime CN1249081C (zh) 1998-12-23 1999-12-22 糖肽衍生物或含有它们的药物组合物

Country Status (23)

Country Link
US (9) US6392012B1 (cg-RX-API-DMAC7.html)
EP (1) EP1140993B1 (cg-RX-API-DMAC7.html)
JP (1) JP4362017B2 (cg-RX-API-DMAC7.html)
KR (1) KR100665204B1 (cg-RX-API-DMAC7.html)
CN (1) CN1249081C (cg-RX-API-DMAC7.html)
AT (1) ATE242783T1 (cg-RX-API-DMAC7.html)
AU (1) AU768204B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI9914221B8 (cg-RX-API-DMAC7.html)
CA (1) CA2336445C (cg-RX-API-DMAC7.html)
CZ (1) CZ301184B6 (cg-RX-API-DMAC7.html)
DE (1) DE69908819T2 (cg-RX-API-DMAC7.html)
DK (1) DK1140993T3 (cg-RX-API-DMAC7.html)
ES (1) ES2201825T3 (cg-RX-API-DMAC7.html)
HK (1) HK1040721B (cg-RX-API-DMAC7.html)
HU (1) HU230190B1 (cg-RX-API-DMAC7.html)
IL (2) IL140093A0 (cg-RX-API-DMAC7.html)
NO (1) NO326066B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ508594A (cg-RX-API-DMAC7.html)
PL (1) PL198311B1 (cg-RX-API-DMAC7.html)
PT (1) PT1140993E (cg-RX-API-DMAC7.html)
SI (1) SI1140993T1 (cg-RX-API-DMAC7.html)
WO (1) WO2000039156A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200007222B (cg-RX-API-DMAC7.html)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6392012B1 (en) * 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU4054900A (en) * 1999-04-02 2000-10-23 Advanced Medicine East, Inc. Desleucyl glycopeptide antibiotics and methods of making same
WO2001057071A2 (en) * 2000-02-04 2001-08-09 Advanced Medicine, Inc. Glycopeptide derivatives having antibiotic activity
DE60136926D1 (de) 2000-05-02 2009-01-22 Theravance Inc Zusammensetzung die eine zyklodextrin und ein glykopeptid-antibiotikum enthält
WO2001083520A2 (en) * 2000-05-02 2001-11-08 Theravance,Inc Polyacid glycopeptide derivatives
EP1276759B1 (en) 2000-05-02 2008-07-30 Theravance, Inc. Reductive alkylation process on glycopeptides
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
AU2001259816A1 (en) 2000-06-22 2002-01-02 Advanced Medecine, Inc. Polyhydroxy glycopeptide derivatives
ES2302733T3 (es) * 2000-06-22 2008-08-01 Theravance, Inc. Derivados carboxi-sacaridos de glucopeptido.
US6905669B2 (en) * 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
EP1295711B1 (en) 2001-09-19 2006-04-12 The Procter & Gamble Company A color printed laminated structure, absorbent article comprising the same and process for manufacturing the same
TWI335332B (en) 2001-10-12 2011-01-01 Theravance Inc Cross-linked vancomycin-cephalosporin antibiotics
US20040033986A1 (en) 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
CN101404986B (zh) 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
ES2384707T3 (es) 2002-05-24 2012-07-11 Theravance, Inc. Antibióticos entrecruzados de glucopéptidos y cefalosporinas
AU2003243574A1 (en) 2002-06-17 2003-12-31 Theravance, Inc. PROCESS FOR PREPARING N-PROTECTED Beta-AMINO ALDEHYDE COMPOUNDS
US20060135568A1 (en) * 2002-07-09 2006-06-22 Townsend Craig A Methods of treating microbial infections in humans and animals
US20060074014A1 (en) * 2002-11-18 2006-04-06 Vicuron Pharmaceuticals Inc. Dalbavancin compositions for treatment of bacterial infections
EP1565201B1 (en) * 2002-11-18 2018-10-31 Vicuron Pharmaceuticals, Inc. Methods of administering dalbavancin for treatment of bacterial infections
ES2335013T3 (es) * 2003-05-23 2010-03-18 Theravance, Inc. Antibioticos de glucopeptido-cefalosporina reticulados.
WO2005005436A2 (en) * 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics
DE102004055582A1 (de) 2004-11-18 2006-05-24 Bayer Cropscience Ag N-Heterocyclyl-phthalsäurediamide
WO2006057303A1 (ja) 2004-11-29 2006-06-01 National University Corporation Nagoya University グリコペプチド抗生物質モノマー誘導体
US8304597B2 (en) 2004-12-15 2012-11-06 The Procter And Gamble Company Method of using an absorbent article having a functional enhancement indicator
US20070185015A1 (en) * 2005-02-28 2007-08-09 Chiron Corporation and North China Pharmaceutical Corporation Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
CA2623198C (en) 2005-09-22 2014-08-05 Medivas, Llc Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
WO2007038246A2 (en) 2005-09-22 2007-04-05 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
US20070173438A1 (en) * 2006-01-13 2007-07-26 The Scripps Research Institute [PSI[CH2NH]PG4] glycopeptide antibiotic analogs
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
EP2238102A4 (en) * 2007-12-26 2011-03-09 Lead Therapeutics Inc NEW HALF-SYNTHETIC GLYCOPEPTIDES AS ANTIBACTERIAL AGENTS
AU2008342149A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivative
US8841440B2 (en) 2008-04-01 2014-09-23 Cornell University Organo-soluble chitosan salts and chitosan-derived biomaterials prepared thereof
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
CN101928330B (zh) * 2009-06-26 2013-10-16 上海来益生物药物研究开发中心有限责任公司 一种新的化合物及其应用
WO2012129493A1 (en) * 2011-03-24 2012-09-27 Seachaid Pharmaceuticals, Inc. Vancomycin derivatives
WO2014152332A1 (en) 2013-03-15 2014-09-25 Melinta Therapeutics, Inc. Methods of treating infections in overweight and obese patients using antibiotics
WO2015040467A1 (en) * 2013-09-23 2015-03-26 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Vancomycin-sugar conjugates and uses thereof
CA2972276A1 (en) * 2014-12-25 2016-06-30 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Glycopeptides and uses thereof
CA3011208A1 (en) * 2016-01-15 2017-07-20 Universitat Hamburg Methods for the production of rhamnosylated flavonoids
CN108698974A (zh) * 2016-01-28 2018-10-23 阿卡特肖勒公司 光裂解底漆组合物和使用方法
CN107325159A (zh) * 2016-04-29 2017-11-07 中国科学院上海药物研究所 一类万古霉素衍生物、其制备方法、药物组合物和用途
GB2577420B (en) 2017-05-22 2022-07-06 Insmed Inc Glycopeptide derivative compounds and uses thereof
CN107987131B (zh) * 2017-11-16 2021-03-09 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的化合物、其制备方法和应用
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
NL2023883B1 (en) * 2019-09-24 2021-04-26 Univ Leiden Antibiotic compounds
CN111620931B (zh) * 2020-06-12 2021-12-17 苏州博源医疗科技有限公司 万古霉素衍生物及其制备方法和应用
CN114213284B (zh) * 2022-01-04 2023-08-01 丽珠集团福州福兴医药有限公司 (9h-芴-9-基)-癸基(2-氧代乙基)氨基甲酸甲酯及其合成方法
CN121270649A (zh) * 2024-07-03 2026-01-06 烟台新药创制山东省实验室 一类万古霉素衍生物、其制备方法、药物组合物和用途

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4497802A (en) 1983-10-21 1985-02-05 Eli Lilly And Company N-Acyl glycopeptide derivatives
US4914187A (en) 1984-11-13 1990-04-03 Gruppo Lepetit S.P.A Ester derivatives of antibiotic L 17046
GB8428619D0 (en) * 1984-11-13 1984-12-19 Lepetit Spa Derivatives of antibiotic l 17046
US4698327A (en) 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
GB8704847D0 (en) * 1987-03-02 1987-04-08 Lepetit Spa Substituted alkylamides of teicoplanin compounds
FR2632185B1 (fr) * 1988-06-01 1992-05-22 Rhone Poulenc Chimie Silice pour compositions dentifrices compatible notamment avec le zinc
GB8817397D0 (en) * 1988-07-21 1988-08-24 Lepetit Spa N15-alkyl & n15 n15-di-alkyl derivatives of teicoplanin antibiotics carrying functional groups on alkyl side chain
US5534420A (en) 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
DE68925806T2 (de) * 1988-12-27 1996-09-26 Lepetit Spa C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
IE64155B1 (en) * 1989-03-29 1995-07-12 Lepetit Spa New substituted alkylamide derivatives of teicoplanin
ZA909847B (en) 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
AU647122B2 (en) 1990-05-28 1994-03-17 Gruppo Lepetit S.P.A. C63-amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy- teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
WO1992017456A1 (fr) 1991-03-26 1992-10-15 Fujisawa Pharmaceutical Co., Ltd. Derive d'acide amine et sel dudit derive
DK0596929T3 (da) * 1991-07-29 1995-09-11 Lepetit Spa Amidderivater af antibiotikum A 40926
US5750509A (en) 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
NZ270387A (en) 1994-01-28 1996-11-26 Lilly Co Eli Glycopeptide antibiotic, its production and compositions thereof
US5840684A (en) 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
IT1282586B1 (it) 1996-02-08 1998-03-31 Chemical And Biolog Ind Composizioni farmaceutiche per il trattamento biologico delle infezioni dovute a ceppi di enterococcus faecium resistenti agli
JP2000507246A (ja) 1996-03-21 2000-06-13 トランセル テクノロジーズ インク. 固体相のリポグリコペプチドライブラリー、組成物及び方法
WO1997038702A1 (en) 1996-04-12 1997-10-23 Eli Lilly And Company Covalently-linked glycopeptide dimers
WO1997038706A1 (en) 1996-04-12 1997-10-23 Eli Lilly And Company Glycopeptide compounds
DK0912604T3 (da) 1996-04-23 2002-03-25 Biosearch Italia Spa Forbedret kemisk fremgangsmåde til fremstilling af amidderivater af A 40926 antibiotikum
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5916873A (en) 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
US5919771A (en) 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US5952310A (en) 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5977063A (en) 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
FR2778184A1 (fr) 1998-02-20 1999-11-05 Advanced Medicine Inc Composes a liaisons multiples antibacteriens nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
CA2330619A1 (en) 1998-05-01 1999-11-11 Eli Lilly And Company N1-modified glycopeptides
EP1095058A4 (en) 1998-07-14 2003-07-16 Univ Princeton GLYCOPEPTIDANTIBIOTICS, COMBINATIONAL LIBRARIES OF GLYCOPEPTIDANTIBIOTICS AND METHOD FOR THEIR PRODUCTION
US6392012B1 (en) * 1998-12-23 2002-05-21 Advanced Medicine, Inc. Glycopeptide derivatives and pharmaceutical compositions containing the same
UA75083C2 (uk) 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
ES2384707T3 (es) 2002-05-24 2012-07-11 Theravance, Inc. Antibióticos entrecruzados de glucopéptidos y cefalosporinas
WO2005005436A2 (en) 2003-07-11 2005-01-20 Theravance, Inc. Cross-linked glycopeptide-cephalosporin antibiotics

Also Published As

Publication number Publication date
HUP0400887A3 (en) 2012-09-28
US6962970B2 (en) 2005-11-08
AU768204B2 (en) 2003-12-04
US6949681B2 (en) 2005-09-27
JP4362017B2 (ja) 2009-11-11
DK1140993T3 (da) 2003-10-06
SI1140993T1 (en) 2003-12-31
NO326066B1 (no) 2008-09-08
HK1040721A1 (en) 2002-06-21
US20030060598A1 (en) 2003-03-27
US6455669B1 (en) 2002-09-24
EP1140993B1 (en) 2003-06-11
NZ508594A (en) 2003-05-30
HUP0400887A2 (hu) 2004-08-30
US20040204346A1 (en) 2004-10-14
WO2000039156A1 (en) 2000-07-06
BRPI9914221B8 (pt) 2021-05-25
BR9914221A (pt) 2001-06-26
ATE242783T1 (de) 2003-06-15
ES2201825T3 (es) 2004-03-16
BR9914221B1 (pt) 2013-12-31
US8030445B2 (en) 2011-10-04
US7101964B2 (en) 2006-09-05
ZA200007222B (en) 2002-03-06
NO20006323D0 (no) 2000-12-12
US6392012B1 (en) 2002-05-21
DE69908819D1 (de) 2003-07-17
US6444786B1 (en) 2002-09-03
PL198311B1 (pl) 2008-06-30
HK1040721B (en) 2003-10-17
CN1315961A (zh) 2001-10-03
US20090215982A1 (en) 2009-08-27
US20060241024A1 (en) 2006-10-26
US7723470B2 (en) 2010-05-25
US20080103292A1 (en) 2008-05-01
CA2336445C (en) 2011-07-19
KR100665204B1 (ko) 2007-01-04
HU230190B1 (hu) 2015-09-28
CZ301184B6 (cs) 2009-12-02
PL348451A1 (en) 2002-05-20
IL140093A0 (en) 2002-02-10
JP2002533472A (ja) 2002-10-08
DE69908819T2 (de) 2004-05-06
US7351791B2 (en) 2008-04-01
IL140093A (en) 2006-06-11
NO20006323L (no) 2001-02-12
US20050239690A1 (en) 2005-10-27
AU3127300A (en) 2000-07-31
CA2336445A1 (en) 2000-07-06
CZ200122A3 (en) 2001-06-13
EP1140993A1 (en) 2001-10-10
PT1140993E (pt) 2003-10-31
KR20010085857A (ko) 2001-09-07

Similar Documents

Publication Publication Date Title
CN1315961A (zh) 糖肽衍生物或含有它们的药物组合物
CN1223378C (zh) 含有糖肽抗生素和环糊精的药物组合物
CN1034506C (zh) 含糖肽衍生物的药物组合物的制备方法
CN1437611A (zh) 糖肽膦酸盐衍生物
CN1671732A (zh) 纯化糖肽膦酸酯衍生物的方法
CN1425025A (zh) 作为抗菌剂的新颖的脂肽
CN1423656A (zh) 作为抗菌剂的脂肽
CN87106483A (zh) 糖肽抗生素的制备方法
CN1423655A (zh) 作为抗菌剂的新颖的脂肽
CN1129596C (zh) 头孢烯化合物的合成中间体
CN1551887A (zh) 新颖的缩肽和制备它们的方法
CN101065365A (zh) 二苯并二氮杂䓬酮类似物,它们的生产方法和它们作为药物的用途
CN1373770A (zh) 假单胞菌素前药
US20030008812A1 (en) Glycopeptide derivatives
CN1030079A (zh) 制备2-甲氧基甲基-青霉烯衍生物的方法
CN1279906C (zh) 硫藤黄菌素二氧化物及其衍生物在制备用于治疗cns疾病的药物中的用途及其制备方法
CN1311794A (zh) 气丝菌素类似物、它们的制备和用途
CN1349407A (zh) 每月一次给药治疗链球菌肺炎感染
CN1157482C (zh) 具有抗真菌活性的化合物及其制备方法
CN1827638A (zh) 一类新型万古霉素和去甲万古霉素的衍生物,制备方法和用途
CN1923196A (zh) 含有左奥硝唑的药物组合物及其应用
CN1914221A (zh) 6-11双环酮大环内酯衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: SCHWAN BIOPHARMA ANTIBIOTICS IP CO., LTD.

Free format text: FORMER OWNER: SCHWAN PHARMACY

Effective date: 20140806

C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20140806

Address after: American California

Patentee after: THERAVANCE BIOPHARMA ANTIBIOTICS IP LLC

Address before: American California

Patentee before: Shiwan Pharmaceuticals Inc.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20190417

Address after: Tennessee

Patentee after: Cumberland Pharmaceuticals Inc.

Address before: American California

Patentee before: THERAVANCE BIOPHARMA ANTIBIOTICS IP LLC

CX01 Expiry of patent term

Granted publication date: 20060405

CX01 Expiry of patent term